Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects
NCT02952547
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Co-administration of DWC20155 and DWC20156
DRUG:
DWJ1366 Tab.
Sponsor
Daewoong Pharmaceutical Co. LTD.